NEWM&A

Werewolf Therapeutics (HOWL) Files Form 13D/A on May 5

Published on 5/5/2026

#HOWL#SEC#M&A
Werewolf Therapeutics (HOWL) Files Form 13D/A on May 5

AI Summary

Werewolf Therapeutics (HOWL) submitted a Form 13D/A to the SEC on May 5. This filing indicates significant ownership changes or intentions by major shareholders, which could influence stock prices and investor sentiment. The document is crucial for transparency and informs the market of potential shifts in control or strategies. Such filings often lead to market reactions as stakeholders analyze the implications for company direction and governance.

Source: Read original article (opens in new tab)

Related News

Truist Financial (TFC) Files PRE 14A for Shareholder Meeting Details
Regulation

Truist Financial (TFC) Files PRE 14A for Shareholder Meeting Details

May 5

A10 Networks (ATEN) Form 144 Filed on May 5, 2023
M&A

A10 Networks (ATEN) Form 144 Filed on May 5, 2023

May 5

Solmate Infrastructure (SLMT) Announces 1-for-10 Reverse Stock Split Date
M&A

Solmate Infrastructure (SLMT) Announces 1-for-10 Reverse Stock Split Date

May 5

FTAI Aviation (FTAI) Director Sells $61.5M in Shares
M&A

FTAI Aviation (FTAI) Director Sells $61.5M in Shares

May 5